Monthly Archives: October 2019

Future Farm’s Maine Hemp Harvest Nearing Completion

Future Farm’s Maine Hemp Harvest Nearing Completion

Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that the harvest of its Maine hemp crop is nearing completion, with over 75% of the field harvested. The remaining hemp plants will be shipped to the Company’s Belfast facility by November 2nd, on schedule and according to plan. The team is hanging the plants to dry in a climate-controlled room in Belfast, Maine. After approximately two weeks, the plants will be prepared for processing into high quality CBD products.

“We greatly appreciate the dedication and hard work of our team over these last few weeks,” comments William Gildea, Future Farm’s CEO. “Completing this harvest is especially timely since just this week the USDA released its interim hemp regulations. Knowing that we are already well-positioned in an industry with economic opportunities in new markets is very exciting.”

The Company is also pleased to announce that its Q2 2020 financial statements have been filed for the period ended August 31, 2019. Filings are available on SEDAR.

The Company would also like to remind its shareholders that it has changed the date of its Annual General Meeting of Shareholders to December 16, 2019. The Company set October 17, 2019 as the record date for notice, voting and beneficial ownership determination date.

The Company also announces that the Board of Directors has approved the cancellation of 1,650,000 incentive stock options currently exercisable at $0.31CDN and 4,231,250 incentive stock options currently exercisable at $0.395CDN.

For further information, contact Investor Relations at or (888) 387-3761 ext. 710.

On behalf of the Board,

Future Farm Technologies Inc.

William Gildea, Chairman and CEO

About Future Farm Technologies Inc. 

Future Farm Technologies is a Canadian public company that is poised to be a leading supplier of hemp-derived CBD products to meet the burgeoning demand in the U.S. and global markets. The Company’s current key initiatives are the cultivation and processing of its hemp crop growing in Maine, the pursuit of other hemp-related opportunities throughout the U.S. and the development of elite strains of cannabis in Canada.

Future Farm’s seasoned management team brings a deep understanding of operations and agriculture with the financial and regulatory expertise needed to become an industry leader in the evolving market for CBD and related compounds.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. 

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking.  Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements.  Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions.  There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties.  We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Investor Relations
888-387-3761 x710


Share - Facebook

Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Thu, 31 Oct 2019 12:15:46 +0000

Vapen MJ Announces Cannabis THC Extraction, Production and Cultivation Partnership in Oklahoma

Vapen MJ Announces Cannabis THC Extraction, Production and Cultivation Partnership in Oklahoma

Vapen MJ (OTCQX:VAPNF; CSE: VAPN) (“Vapen MJ”) a fully integrated manufacturer and distributor of cannabis THC and hemp CBD products under the Vapen Brand, leveraging core expertise in extraction, outdoor cultivation and marketing to build wholesale distribution through revenue and profit sharing partnerships, announced today a cannabis THC production, extraction and cultivation partnership with the principals and founders of Texoma House of Cannabis to form Vapen Oklahoma, LLC in Oklahoma .

Texoma House of Cannabis has a licensed retail dispensary, as well as Texoma Cultivation greenhouse and outdoor growing operations in Madill, OK. Oklahoma is one of the fastest growing medical marijuana markets in the U.S. according to the August 2019 Annual Marijuana Business Factbook report, based on the average number of patients as a percentage of the population.

The new, state-of-the-art extraction and production facility is anticipated to be fully operational and selling product wholesale to licensed Oklahoma dispensaries throughout the state by the end of 2019. Vapen MJ will provide the Vapen brand, standard operating procedures (SOPs), and back office support for the partnership. The partnership with Texoma will facilitate the launch of Vapen branded product including a line of THC concentrates, edibles and extraction products to dispensaries in the state of Oklahoma .

“We are strategically adding capacity in a new market that has one of the fastest-growing medical marijuana patient populations. We will be launching Vapen branded, safe products that deliver our high quality and purity standards,” commented Thai Nguyen , Founder and Chief Executive Officer of Vapen MJ. “Our partner, with a retail presence and outdoor growing capability in the state of Oklahoma as well as greenhouse operations, has built a solid reputation for quality cannabis products. This relationship underscores our commitment to expanding through partnerships in new markets as we execute our growth strategy to expand our U.S. presence and increase our brand awareness.”

For more information please visit our websites at or

About Texoma House of Cannabis

Texoma House of Cannabis is a state-licensed marijuana dispensary in Southern Oklahoma that stemmed from a desire to supply top-quality hemp-derived alternative medicine to the people who need it in the Sooner State. We aim to become the go-to resource for anything related to medical marijuana — from serving as an educational resource on the latest rules and regulations and how to apply for a medical marijuana patient license to helping customers determine and purchase the best products and accessories to manage their symptom relief. THC Texoma is a proud member of the National Cannabis Industry Association.

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand.  Vapen MJ expansion plans include partnering with cannabis license holders and hemp farms in multiple states within the US.

We seek Safe Harbour.


View original content:

SOURCE Vapen MJ Ventures Corporation


Share - Facebook

Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Tue, 29 Oct 2019 13:13:45 +0000

What Can The End Of Alcohol Prohibition Teach Cannabis Entrepreneurs?

What Can The End Of Alcohol Prohibition Teach Cannabis Entrepreneurs?

eCann Media is proud to showcase our portfolio of investments and subsidiaries. We have completed numerous investments across multiple verticals and sectors in the cannabis industry. Requesting an invitation will enable the eCann team to consider your eligibility for investment as well help us to identify the opportunities that best fit your needs and investment objectives.

Published at Fri, 18 Oct 2019 18:00:00 +0000

Canopy Rivers Inc (OTCMKTS:CNPOF) Pleased After JWC Obtains Its License Amendment

Canopy Rivers Inc (OTCMKTS:CNPOF) Pleased After JWC Obtains Its License Amendment

Canopy Rivers Inc (OTCMKTS:CNPOF) is a venture firm that focuses on Cannabis and related products. It was today that the business revealed the latest major development of its portfolio company James E. Wagner Cultivation Corporation.

A close outlook

According to
Canopy Rivers, James E. Wagner Cultivation Corporation just obtained a license
amendment from Health Canada. This development will see it engage in production
activities across four of its new flowering rooms. This will be taking place at
its Ontario flagship facility.

The Chief
Operating Officer at Canopy Rivers Olivier Dufourmantelle has spoken about the
most recent development. According to the official, the license amendment is a
clear demonstration of the company’s recognition of JWC. This is in terms of
its disciplined approach to expansion and business operations.

He opined, “Through its supply agreement
with TerrAscend, JWC has an active role in the Canopy Rivers ecosystem. We’ve
seen that companies that work together thrive together, and we think this
Health Canada approval will enable JWC to increase production and further
collaborate within the Canopy Rivers ecosystem.”

Growth operations

Several market
observers have spoken regarding the additional flowering rooms. They have
termed it part of the company;’s dedicated efforts towards a program that will
help broaden JWC’s existing production capacity. The facility will engage in
wide-scale production activities, and it measures 345,000 square feet.

The company has
also disclosed that the newly licensed areas will be operating using a
proprietary GrowthSTORM™ Dual Droplet™ System. This is a unique practice where
plant roots are suspended in the air and also get misted at some particular
intervals. Special nutrient solutions that work well for the system are put
into use.

The best thing is
that a proper combination with the GrowthSTORM™ Management system guarantees
outstanding results. It is a remarkable cultivation technique that gives room
for the company to engage in the collection of data and its analysis as well.
Such activities are important for the delivery of top-quality cannabis in a
consistent way.

The facility will
be undertaking its full operations anytime from now. Reports indicate that the
new flowering rooms will increase the production capacity by a significant
margin. The growing space will increase from about 22,000 square feet to 44,500
square feet.

Published at Fri, 25 Oct 2019 04:56:32 +0000

Choom’s New CEO: One More Reason For Investors To ‘Say Hello’ To Choom

Choom’s New CEO: One More Reason For Investors To ‘Say Hello’ To Choom

Canada’s cannabis sector is heating up. Retail sales are rising strongly. Phase 2 of Canada’s cannabis legalization is officially here and new products are expected to hit store shelves in December.

Canada’s cannabis retail leaders have been stepping up their own activities. More store openings. More acquisitions.

With one of these cannabis retail leaders, Choom Holdings (CAN:CHOO / US:CHOOF), it also means adding retail clout to its management team. On October 25, 2019; Choom announced that Corey Gillon has been appointed as the company’s new CEO.

Investors following Choom will already be familiar with this name, as will investors with broader knowledge of consumer retail. Gillon is a retail sector veteran as well as a graduate of the Harvard Business School.

He rose to prominence in consumer retail during his 15 years with Walmart, where he directed Walmart’s Western Canada operations, covering 100 retail stores. Gillon left Walmart to assume the role of Senior Vice President, Retail Division with dynamic clothing brand, Aritzia.

Gillon originally joined Choom in July 2019, coming aboard as President, with Chris Bogart continuing in his role as CEO. Now Gillon and Bogart are swapping positions. Gillon becomes the CEO, with Bogart stepping into the role of President.

For investors, the move helps to solidify Choom’s position as one of Canada’s leading cannabis retail companies.

This follows closely on the heels of Choom’s new development permit to gain entry into the key Vancouver cannabis market, as well as several more store-openings in Alberta.

Cannabis stock valuations are down. But the Canadian cannabis sector itself is surging strongly. Sustained monthly double-digit gains in sales. Growing momentum in licensing and opening new cannabis stores.

Phase 2 adds a wide array of new cannabis products and is also expected to generate 3 million new cannabis consumers, increasing the consumer base by roughly 50%.

For all of these reasons, Canadian cannabis retail is looking especially attractive. With Choom’s latest management appointment, investors have one more reason to “Say hello to Choom™”.

Published at Fri, 25 Oct 2019 22:45:37 +0000

This Week in Cannabis Investing October 25th

This Week in Cannabis Investing October 25th

This week marks the first full week in the second year of cannabis legalization in Canada, and the arrival of Phase 2 – with a wide new variety of cannabis products. As we surveyed Canada’s cannabis market, we see a mixed picture.

Growth in sales is now increasing at a robust rate. But the cannabis black market still controls much too much of the overall market.

Valuations for Canadian marijuana stocks remain absurdly low. But a number of cannabis companies are moving aggressively forward on operations and making the transition to profitability.

In the United States, the story continues to be regulatory headwinds. SAFE remains before the Senate, with no assurance it will pass. The FDA still hasn’t moved on regulating CBD commerce. Meanwhile, the regulatory failure that has caused vaping illnesses/deaths among some cannabis users highlights the need for full legalization.

Monday, as promised, The Seed Investor took its own look at Canada’s cannabis industry as it celebrates the first anniversary of legalizing recreational cannabis. An industry that has tripled in size over one year. Strong, consistent month-over-month gains in cannabis sales. And cannabis companies that are already becoming profitable.

Now Phase 2 is here, with new cannabis products due to start hitting store shelves in December. It’s expected to add roughly 3 million new consumers of legal cannabis – roughly a 50% increase. For all these reasons, we look ahead optimistically to Year 2.

The flip side of this picture in Canada’s cannabis market is that the cannabis black market remains much too large. We observed that it still controls approximately 85% of overall cannabis revenues in Canada, considerably more than previous projections.

Clearly, Canada’s provincial governments are to blame. Several provinces (notably Ontario and British Columbia) have been abysmally slow in licensing retail cannabis stores. The result is more sales going to the black market.

Tuesday, we offered investors information on where we see particularly prospective opportunities in the Canadian cannabis industry. Specifically, we like the Canadian cannabis retailers and extraction specialists.

Each of these sub-sectors is currently well-positioned in Canada, for different reasons. We provided some of the leading names from among these companies for investors.

Wednesday, we turned our gaze to the U.S. cannabis industry. The Senate is currently holding a hearing on “marijuana and public health”. The Seed Investor is skeptical of this hearing, to put it in polite terms.

Senate co-chair John Cornyn (R-TX) is an anti-cannabis dinosaur, strongly opposed to cannabis legalization. Other key figures in the hearing are equally uninformed about cannabis. We see this as a ploy by Cornyn to undermine efforts to pass the SAFE bill for cannabis banking.

Then it was back to more cannabis news from Canada. Statistics Canada came out with its August numbers for Canadian cannabis sales, and they were big. Over CAD$127 million in sales. An 18.6% month-over-month jump versus July cannabis sales. The second consecutive month of cannabis sales topping $100 million.

Looking over recent months, sales are now accelerating. After a slow month in June (only a 6.2% increase), Canadian cannabis sales heated up over the summer. July’s sales represented a 12.5% month-over-month gain. Now August sales have continued to accelerate at that pace.

Thursday, we took a look at one of Canada’s leading cannabis retailers, Choom Holdings (CAN:CHOO / US:CHOOF). Choom announced receiving a new development permit for a cannabis store.
Why is this big news? Because it’s a permit for a Vancouver cannabis store location. Vancouver is presently one of Canada’s most under-served cannabis markets.

Friday, we started the day with an article on the strategy of Canopy Growth (US:CGC / CAN:WEED) to gain an inside track on the ultra-important senior’s market for cannabis. Senior’s have more health needs than the rest of us. They are also prime candidates for all of the general health-promoting properties of cannabis.

Through an arrangement with CARP (Canada’s advocacy group for older Canadians), Canopy Growth offers CARP members a 20% discount on selected cannabis products. While Canada’s industry leader has received a lot of media criticism, this is another strong move for Canopy.

Then Choom was back in the news. This time the company was announcing a new CEO. Corey Gillon is moving from his position as President into this senior role.

For those new to Choom, Gillon is a retail sector heavyweight. He spent 15 years with Walmart rising to lead its Western Canada division. From there he moved on to become Senior VP with Aritzia. Now Gillon is bringing all that expertise to his new position as Choom’s CEO.

These were some of the leading stories that we covered this week from the world of cannabis investing. As 2019 starts to wind down, we see the cannabis industry picking up in Canada. In the U.S., the industry remains dependent on achieving some regulatory milestones and moving past the health issues surrounding vaping.

DISCLOSURE: Choom Holdings is a client of The Seed Investor

Published at Fri, 25 Oct 2019 20:58:18 +0000

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Provides Details About Its Latest Cultivation Expansion License

Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) Provides Details About Its Latest Cultivation Expansion License

Emerald Health Therapeutics Inc

is pleased to receive the full municipal permitting for its properties in
British Columbia. It looks forward to commencing its operations at two of its
78,000 square foot greenhouses. Health Canada has been reviewing the company
and after realizing it had met the required conditions gave it the cultivation
license amendment.

A close outlook

Emerald is
currently staring at an additional license 50,000 square feet growing space,
and some other seven grow areas. At the current state of affairs, the business
guru can commence its operations at the site. In a statement, the company said
it was making plans to kickstart its planting activities at the site. If all
moves according to plan, the planting activities may reach completion by the
end of Q4.Probably, the first harvest may be in January 2020.

The Chief
Executive Officer of Emerald Riaz Bandali has spoken about the matter. He says
that they look forward to starting the planting activities. According to the
official, the Metro Vancouver organic operation will see the company move to
new financial heights.

He also
congratulated the company for its most recent achievement. He thinks that the
licensing of the Québec premium craft product indoor cultivation site is a
major step forward for them. Emerald Health Therapeutics seeks to produce
industry-leading products in terms of quality, and it will make it happen in
the Metro Vancouver site. The business giant says it will be counting on its
extensive experience in production and compliance to make it in the dynamic
markets. As always, product consumers in the market aspire to obtain premium
organic products, and this is what the company is working towards.

Other major developments

Emerald Health
Therapeutics has also spoken about the latest development regarding its
wholly-owned production facility, Verdélite. The facility obtained a license
amendment permitting from Health Canada. With this development, it seeks to
focus on the sale and distribution of packaged, branded dried cannabis
products. It will distribute the products to the authorized private retailers
and territorial wholesalers. All the products being package by Verdélite are
under the Emerald brand.

The other thing
is that Emerald Health Therapeutics has distanced itself from certain terms
reading its agreement with Pure Sunfarms Corp. It asserts that it doesn’t have
any liability in the deal. Pure Sunfarms Corp happens to be Emerald’s 50%-owned
joint venture, and the exchanges are in line with the current Supply Agreement
between the two. The company is not happy with the way the joint venture
conducted the Supply Agreement.

Published at Thu, 24 Oct 2019 12:01:16 +0000